Triphala 166mg
Food supplement declared in France, declaration No 2024-7-201, decision dated 3 July 2024
Triphala 166mg is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- BIOFILUX NUTRITION SARL
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 332 mg
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
Declaration 143413, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Phyllanthus emblica L. | Fruit | Extrait sec hydroalcoolique | 112 mg |
| Terminalia bellerica (Gaertn.) Roxb. | Fruit | Extrait sec hydroalcoolique | 110 mg |
| Terminalia chebula Retz. | Fruit | Extrait sec hydroalcoolique | 110 mg |
Additives
E414, E464
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Ce complément alimentaire doit être utilisé dans le cadre d’un régime alimentaire varié et équilibré. Il est important d’avoir un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Conserver dans un endroit frais et sec.Ne convient pas aux enfants, aux femmes enceintes et en période d’allaitement.Tenir hors de portée des jeunes enfants
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Triphala 166mg SL, declared in 2025 : same declared composition